BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 37611628)

  • 21. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
    Grassly NC; Pons-Salort M; Parker EPK; White PJ; Ferguson NM;
    Lancet Infect Dis; 2020 Dec; 20(12):1381-1389. PubMed ID: 32822577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of contact tracing in the control of infectious diseases: a systematic review.
    Hossain AD; Jarolimova J; Elnaiem A; Huang CX; Richterman A; Ivers LC
    Lancet Public Health; 2022 Mar; 7(3):e259-e273. PubMed ID: 35180434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics.
    Libin PJK; Willem L; Verstraeten T; Torneri A; Vanderlocht J; Hens N
    PLoS Comput Biol; 2021 Mar; 17(3):e1008688. PubMed ID: 33690626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study.
    Ritsema F; Bosdriesz JR; Leenstra T; Petrignani MWF; Coyer L; Schreijer AJM; van Duijnhoven YTHP; van de Wijgert JHHM; Schim van der Loeff MF; Matser A
    JMIR Mhealth Uhealth; 2022 Aug; 10(8):e31099. PubMed ID: 35867842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the impact of test-trace-isolate for COVID-19 management and alternative strategies.
    Zhang K; Xia Z; Huang S; Sun GQ; Lv J; Ajelli M; Ejima K; Liu QH
    PLoS Comput Biol; 2023 Sep; 19(9):e1011423. PubMed ID: 37656743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A network modelling approach to assess non-pharmaceutical disease controls in a worker population: An application to SARS-CoV-2.
    Hill EM; Atkins BD; Keeling MJ; Dyson L; Tildesley MJ
    PLoS Comput Biol; 2021 Jun; 17(6):e1009058. PubMed ID: 34133427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mathematical model to assess the effectiveness of test-trace-isolate-and-quarantine under limited capacities.
    Heidecke J; Fuhrmann J; Barbarossa MV
    PLoS One; 2024; 19(3):e0299880. PubMed ID: 38470895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study.
    Quilty BJ; Clifford S; Hellewell J; Russell TW; Kucharski AJ; Flasche S; Edmunds WJ;
    Lancet Public Health; 2021 Mar; 6(3):e175-e183. PubMed ID: 33484644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using a household-structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic.
    Fyles M; Fearon E; Overton C; ; Wingfield T; Medley GF; Hall I; Pellis L; House T
    Philos Trans R Soc Lond B Biol Sci; 2021 Jul; 376(1829):20200267. PubMed ID: 34053253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the Swiss Digital Contact-Tracing App Over Various SARS-CoV-2 Pandemic Waves: Repeated Cross-sectional Analyses.
    Daniore P; Nittas V; Ballouz T; Menges D; Moser A; Höglinger M; Villiger P; Schmitz-Grosz K; Von Wyl V
    JMIR Public Health Surveill; 2022 Nov; 8(11):e41004. PubMed ID: 36219833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact tracing indicators for COVID-19: Rapid scoping review and conceptual framework.
    Vogt F; Kurup KK; Mussleman P; Habrun C; Crowe M; Woodward A; Jaramillo-Gutierrez G; Kaldor J; Vong S; Del Rio Vilas V
    PLoS One; 2022; 17(2):e0264433. PubMed ID: 35226699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Contact Tracing as an Indicator for Evaluating a Pandemic Situation: Simulation Study.
    Marques-Cruz M; Nogueira-Leite D; Alves JM; Fernandes F; Fernandes JM; Almeida MÂ; Cunha Correia P; Perestrelo P; Cruz-Correia R; Pita Barros P
    JMIR Public Health Surveill; 2023 Apr; 9():e43836. PubMed ID: 36877958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and resource requirements of test, trace and isolate strategies for COVID in the UK.
    He B; Zaidi S; Elesedy B; Hutchinson M; Paleyes A; Harling G; Johnson AM; Whye Teh Y;
    R Soc Open Sci; 2021 Mar; 8(3):201491. PubMed ID: 33959319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of COVID-19 testing and contact tracing in a US city.
    Wang X; Du Z; James E; Fox SJ; Lachmann M; Meyers LA; Bhavnani D
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2200652119. PubMed ID: 35969766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.
    Zirbes J; Sterr CM; Steller M; Dapper L; Nonnenmacher-Winter C; Günther F
    Antimicrob Resist Infect Control; 2021 Jul; 10(1):102. PubMed ID: 34215330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of non-pharmaceutical public health interventions against COVID-19: A systematic review and meta-analysis.
    Iezadi S; Gholipour K; Azami-Aghdash S; Ghiasi A; Rezapour A; Pourasghari H; Pashazadeh F
    PLoS One; 2021; 16(11):e0260371. PubMed ID: 34813628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.